-
Should Biotech Investors Take Hillary Clinton's Drug Pricing Plan Seriously?
Wednesday, September 23, 2015 - 7:56am | 584Read More...Democratic presidential frontrunner Hillary Clinton has sent biotech stocks plummeting this week after announcing the creation of a new plan to fight drug price gouging. Evercore ISI believes that there is a very slim chance the plan will ever become law. Political analyst Terry Haines...
-
Don't Worry Investors, Hillary Can't Change Drug Pricing As President
Monday, September 21, 2015 - 3:59pm | 506Read More...Hillary Clinton tweeted that "price gouging" in the specialty drug market is "outrageous." Terry Haines of Evercore ISI commented in a note that there is "almost no chance" of a president legislating drug pricing regulation. An appeal by Democratic candidate to "control" or "gauge" drug pricing...



